This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
antibody
product name :
PRMT4 / CARM1 Antibody (aa45-69) LS-C641
catalog :
LS-C641
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
AntibodyID :
2863
AntibodyName :
LS-C641
TargetSpecies :
Human
Host Species :
Rabbit
Product Name :
PRMT4 / CARM1 Antibody (aa45-69) LS-C641
Specificity :
A mixture of synthetic peptides containing amino acids 45-69 and 595-608 of human PRMT4.
ClonalityDesc :
Polyclonal
AntibodyModification :
Unconjugated
AntigenModification :
aa45-69
PresentationDesc :
PBS, 0.1 mg/ml BSA, 0.02% Sodium Azide
ImmunogenType :
Synthetic peptide
ImmunogenDesc :
Synthetic peptide of human CARM1.
PurificationDesc :
Protein G purified
RecommendedStorageDesc :
Short term: 4°C; Long term: -70°C.
IsotypeName :
IgG
Gene :
PRMT4 / CARM1
StandardGeneSymbol :
CARM1
Reactivity :
Human
Usage :
WB (0.5 - 2 µg/ml)
ShortWebDescription :
CARM1 antibody LS-C641 is an unconjugated rabbit polyclonal antibody to human CARM1 (PRMT4) (aa45-69). Validated for WB.
Synonyms :
CARM1, PRMT4
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
CustomerSupport@lsbio.com
https://www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.